TB-500 Research Guide

Also known as: Thymosin Beta-4 fragment (synthetic)

TB-500 is a synthetic peptide related to a fragment of the naturally occurring protein Thymosin Beta-4 (Tβ4). Research into its investigated roles in cell migration and tissue repair is largely preclinical; direct human evidence for TB-500 specifically is minimal.

Evidence status: Primarily preclinical

Predominantly laboratory and animal research; human evidence is limited or absent.

Educational & research information only. This page summarizes published research and does not provide medical advice, diagnosis, treatment, or dosing guidance. These compounds are not approved treatments. Consult a qualified healthcare professional before any human use.

What it is

TB-500 is a synthetic peptide corresponding to an active region of Thymosin Beta-4 (Tβ4), a protein involved in actin regulation and cell motility. It is important to distinguish TB-500 (the research peptide) from full-length Tβ4, which has itself been the subject of some clinical investigation. TB-500 is not an approved drug.

What researchers are studying

  • Regulation of actin, a cytoskeletal protein central to cell movement and repair (studied via Tβ4 biology).
  • Promotion of cell migration and angiogenesis in wound-healing models.
  • Investigated anti-inflammatory and tissue-remodeling effects in animal studies.

Areas studied

  • Soft-tissue and muscle repair (preclinical)
  • Cardiac tissue repair models (largely via Tβ4, preclinical)
  • Wound healing and cell migration (preclinical)

Evidence summary

Human research

Peer-reviewed human clinical evidence specific to TB-500 is minimal. Some human research exists for full-length Thymosin Beta-4 in areas such as wound healing and ocular surface repair, but those findings should not be assumed to transfer directly to the TB-500 fragment sold for research use.

Preclinical & animal research

Most TB-500/Tβ4 research is preclinical, examining actin regulation, cell migration, angiogenesis, and tissue remodeling in animal and cell-culture models. These results are exploratory and have not been confirmed for the TB-500 peptide in large human trials.

Limitations & uncertainties

  • Human data specific to TB-500 is very limited; much evidence pertains to full-length Tβ4.
  • Findings are primarily from animal and in-vitro studies.
  • Unregulated market means purity and composition vary widely.

Safety & research considerations

TB-500 is not an approved medicine, and controlled long-term human safety data is lacking. It is banned in most competitive sports under anti-doping rules. This page does not provide dosing guidance.

Frequently asked questions

Is TB-500 the same as Thymosin Beta-4?
Not exactly. TB-500 is a synthetic peptide based on an active fragment of Thymosin Beta-4 (Tβ4). Some human research exists for full-length Tβ4, but evidence specific to TB-500 is minimal.
Is TB-500 allowed in sports?
No. TB-500 is prohibited by the World Anti-Doping Agency (WADA) and most sporting bodies.

References & further reading

Curated literature searches on PubMed and clinical-trial registries. A formal, per-study citation list is being expanded during ongoing editorial review.

Reviewed by the Pep God Research Team · Last reviewed July 10, 2026

© 2026 Pep God · All peptide guides · Privacy · Terms

Educational & research information only. Pep God is an AI-powered peptide research and education platform. We are not a doctor and do not provide medical advice, diagnosis, or treatment. Nothing on this platform should be interpreted as medical guidance. Always consult a qualified healthcare professional before using any research compounds. Users assume all risk. Terms